Mona Alfaraj: Therapeutic Apheresis Case Series in Sickle Cell Disease with Fat Embolism Syndrome
Mona Alfaraj, Consultant Hematopathologist and Transfusionist, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Hemoglobin:
“Happy to share that one of our works on therapeutic apheresis has been published. Grateful for the collaboration and the opportunity to contribute in a scientific work that supports better patient care. Proud of the team and the journey behind this work.
For those with trasfusion and apheresis interest, it is worth to emphasize that although plasma is the standard replacement fluid in TPE for FES, a 50:50 replacement protocol using FFP and 5% human albumin was used in both reported cases. This approach aligns with ASFA guidelines , which recommend limiting full FFP replacement to conditions with clear coagulopathy or high bleeding risk.
In sickle cell disease, this mixed replacement strategy aims to reduce donor plasma exposure while ensuring that the FFP provided is sufficient to address any preexisting or exchange-induced coagulopathy.
A similar protocol has been used in other studies involving critically ill patients with sickle cell disease and multi organ failure.
This case series is a step of greater project of optimum utilization of plasma in therapeutic plasma exchange .”
Title: Therapeutic Plasma Exchange as a Rescue Therapy in Sickle Cell Disease-Associated Fat Embolism Syndrome: Case Series and Literature Review
Authors: Abdulmohsen K. Aljishia, Fatimah A. Alrabia, Abdullah M. Al Abbas, Mona M. Alfaraji, Fadhel A. Alomard, Salah Abohelaikac
Read the Full Article on Hemoglobin
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Sep 29, 2026, 14:32Honoring Women Leaders Advancing Research, Care, and Innovation in Thrombosis and Hemostasis – Seminars in Thrombosis and Hemostasis
-
Sep 29, 2026, 14:20Nathan Connell: Key Takeaways from the 8th Aland Island Meeting on von Willebrand Disease
-
Sep 29, 2026, 14:09Mariusz Ratajczak: Are We Inadvertently Destroying the True Regenerative Power of PRP by Discarding the Plasma?
-
Sep 29, 2026, 14:00Nithin M: Proximal Splenic Artery Embolization Prior to Shunt-Directed Variceal Therapy
-
Sep 29, 2026, 13:12Wolfgang Miesbach: Teclistamab Targets the Source of Pathogenic Autoantibodies
-
Sep 29, 2026, 12:37Dan Milikovsky: Uncovering Cerebrovascular Injury in Sickle Cell Disease
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH